RxDoctor Payments Data

Justin Rice, MD

Gastroenterology · West Des Moines, IANPI 1528001724

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 67.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $338 and has fallen 89.0% since, to $37 in 2025. That places this record below the midpoint for gastroenterology clinicians in IA, where the typical reported total is $554.

$598in general payments, 2019–2025

Across 25 payments — averaging $23.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$407
  • AbbVie$134
  • Nestle Healthcare Nutrition Inc.$25
  • Olympus America Inc.$18
  • Sanofi$15

What the payments were for

  • Food & beverage$598100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$598 in reported general payments places this provider in the 50th percentile of 113 gastroenterology providers in Iowa.

See all gastroenterology providers in Iowa

Medicare billing

Part B allowed, 2024
$127,180
Medicare patients
513
Services billed
1,211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates173$11,036
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg167$3,541
DexilantDexlansoprazole12$3,482
Omeprazole241$1,940
Ursodiol11$1,665
Pantoprazole Sodium84$1,111
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg33$496
Esomeprazole Magnesium11$437
Mercaptopurine12$409
Ondansetron Hcl16$329
Nortriptyline Hcl17$68

Paid to pharmacies, not to this prescriber.

Other gastroenterology in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →